Release Date: 26-Sep-2024
In the vast tapestry of India's healthcare landscape, the diagnostics industry has experienced remarkable growth, particularly in the sector of cancer diagnostics. This surge can be attributed to the increasing prevalence and mortality rates associated with cancer, which are rising year by year. Factors such as heightened awareness among the Indian population regarding the importance of cancer diagnostics have led to favorable market conditions for the Indian cancer diagnostics market. Other influential aspects affecting this sector include the development and innovation of various cancer diagnostic test products, advancements in technology, government initiatives, and increased healthcare funding, all serving as key drivers that represent a new frontier in India.
Download Report:
Given the significant rise in popularity of the cancer diagnostic test market in India over the past few years, this trend is also linked to the advancement of novel treatment approaches. Several dynamics contribute to this market trend, including technological progress, the opening of new diagnostic centers, and the rising incidence of cancer cases across the country.
Moreover, the expansion of diagnostic laboratory infrastructure in India is poised to be a significant market stimulus for the Indian diagnostics market in the foreseeable future. To illustrate this point, a recent launch of a multi-center investigation aimed at developing low-cost, point-of-care indigenous human papillomavirus (HPV) tests for cervical cancer detection was inaugurated by the All India Institute of Medical Sciences, Delhi (AIIMS Delhi) in April 2024. This initiative has been propelled by funding from the Grand Challenges India initiative of DBT-BIRAC (Biotechnology Industry Research Assistance Council) in partnership with the World Health Organization’s International Agency for Research on Cancer (IARC).
In addition to this, the growth of online platforms is further enhancing the Indian cancer diagnostic test market year after year. In recent times, numerous online platforms have emerged in India, such as Healthians, 1mg, and Practo, providing a one-stop solution for booking diagnostic tests, including radiology tests such as MRIs and CT scans. This development further signifies the transition of the Indian cancer diagnostic test market towards greater digitization.
Public-private and private-private partnerships are some other crucial components that enhance the cancer diagnostic test market in India. For instance, in May 2024, BD (Becton, Dickinson and Company), a prominent global medical technology firm, announced a strategic collaboration with Healthians, a leading diagnostics service provider in India. This partnership aims to improve cervical cancer screening by providing women in India with the option to self-collect samples in the privacy of their homes. The initiative seeks to increase access to cervical cancer screenings, especially in a country where currently less than 2% of women undergo such testing.
Additionally, in February 2024, AstraZeneca Pharma India signed a memorandum of understanding (MoU) with the National Health Mission, Health and Family Welfare Services, Government of Goa. This collaboration focuses on enhancing lung cancer detection through the use of advanced Artificial Intelligence (AI) screening technology developed by Qure.ai. This innovative initiative is expected to benefit a significant number of patients in district hospitals throughout the state.
Last but not least, recent campaigns, screening camps, and initiatives led by the Indian government, along with the utilization of AI and machine learning technologies, have been implemented to raise awareness and educate the Indian populace about the benefits of diagnostic screening tests for cancer disorders.
Based on the current market trends, the future landscape for the Indian cancer diagnostic test market appears to be highly promising. The presence of several key players such as Apollo Diagnostics, Ganesh Diagnostic, Fortis Hospitals, AIIMS, Tata Memorial Centre (TMC), and others, along with ongoing investments and research collaborations, are key trends shaping the market for cancer diagnostic test products in India. As awareness and accessibility of diagnostic tests continue to grow in both urban and rural areas, it is anticipated that additional cancer diagnostic tests will be launched in the market in the coming years, providing effective management solutions for cancer to Indian consumers at a reasonable cost. India Cancer Diagnostic Test Cancer Screening Market Size, india cancer diagnostics industry, AIIMS cancer diagnostic, HPV cancer diagnostic india, cervical cancer diagnostic, cancer diagnostic test Healthians, cancer diagnostic test 1mg, cancer diagnostic test Practo, cancer diagnosis india Government, cancer diagnosis campaign india, cancer screening camp india, cancer diagnostic initiative india, Ganesh Diagnostic cancer test screening, Apollo Diagnostics cancer test screening, Tata Memorial Centre cancer test screening, Fortis cancer test screening